Clinical Trial Update: The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating first-line treatment with fruquintinib plus albumin paclitaxel and gemcitabine in pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Fruquintinib (fruquintinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN